YAZGAN, S. C. Et Al. 2024. Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysis.. Critical reviews in oncology/hematology , vol.198 , 104376.

YAZGAN, S. C., AKKUŞ, E., Yekeduz, E., & ÜRÜN, Y., (2024). Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysis.. Critical reviews in oncology/hematology , vol.198, 104376.

YAZGAN, SATI Et Al. "Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysis.," Critical reviews in oncology/hematology , vol.198, 104376, 2024

YAZGAN, SATI C. Et Al. "Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysis.." Critical reviews in oncology/hematology , vol.198, pp.104376, 2024

YAZGAN, S. C. Et Al. (2024) . "Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysis.." Critical reviews in oncology/hematology , vol.198, p.104376.

@article{article, author={SATI COŞKUN YAZGAN Et Al. }, title={Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysis.}, journal={Critical reviews in oncology/hematology}, year=2024, pages={104376} }